S. 5571: A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

Loading bill details...

Initial load may take a moment while we fetch the latest data

S. 5571: A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program. | CIV.IQ